Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
43.62
Aug 18 • 4:01 AM ET Dollar change+0.45 Percentage change(1.05%)
Category
Global or ExUS Equities - Industry Sector
Sponsor
Tema
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.75%
Inverse/Leveraged
IPO
Aug 16, 2023
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
No / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
4.13%
SMA50
7.55%
SMA200
17.20%
Return% 1Y
61.82%
Return% 3Y
-
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
0.59%
Flows% 3M
3.11%
Flows% YTD
35.44%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
59
AUM
204.50M
NAV/sh
52W High
43.51 0.25%
52W Low
26.24 66.23%
Volatility
1.85% 2.13%
ATR (14)
0.86
RSI (14)
67.38
Beta
0.71
Rel Volume
0.00
Avg Volume
31.83K
Volume
1
Perf Week
1.32%
Perf Month
8.23%
Perf Quarter
19.23%
Perf Half Y
17.64%
Perf YTD
25.63%
Perf Year
63.43%
Perf 3Y
79.25%
Perf 5Y
-
Perf 10Y
-
Prev Close
43.17
Price
43.62
Change %
1.05%
Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.